Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Footsie gives up gains

Mon, 11th Jan 2010 16:41

The leading share index gave up early gains to finish only slightly higher as euphoria over strong trade figures from China in December gave way to renewed fears over recovery prospects. China's December imports jumped by 55.9% from the same month the previous year, while exports were 17.7% higher. Continued demand for commodities was behind much of the rise, with crude oil imports climbing 25% and copper imports up by more than a quarter.Oil company Cairn Energy was a strong performer after positive noises from Citigroup. The broker says that fast-tracking the multi-well exploration drilling programme in Greenland has made the group its preferred play on frontier exploration in 2010. Dana is its value play while Tullow could be the most exciting story over the first quarter.Elsewhere in the sector, BP and Shell advanced as oil hit a 15-month high.But miners, which had been among the top risers after the Chinese data came out, gave up these gains in afternoon trading. Silver miner Fresnillo slipped back after it dropped out of the race for Canadian mining company Canplats Resources. Eurasian Natural Resources, Vedanta Resources, Anglo American and Xstrata also closed lower.Bank Barclays has received its third upbeat broker note in less than a week. This time it is Citigroup that reckons the bank is cheap, adding that the market is applying too low a rating to Barclays' earnings. Citigroup's target price is 413p, implying 30% upside.Property groups Land Securities and British Land climbed after the former was added to Goldman Sachs' 'conviction buy' list. Segro, which updated on trading today, rose after Goldman upgraded its rating on the stock to 'neutral'. Inès Reinman, Segro's head of Continental Europe, has resigned from the industrial property group barely a year she was promoted to the board. "Current trading and market conditions are in line with our expectations at the time of our Interim Management Statement issued on 5 November 2009," chief executive Ian Coull added.SABMiller fell after it pulled out of the race to buy the Femsa stable of beer brands leaving the way clear for rival brewer Heineken.Cash strapped plumbers merchant Wolseley is to raise just under £24m from the sale of its Irish businesses. WIBHM, a company backed by private investor, is paying €26.5m for Wolseley Ireland Holdings Limited. The exceptional loss on disposal, excluding currency impacts, is expected to be around €55m (£50m).Online gaming group PartyGaming has tied up an an exclusive, five-year agreement with state-controlled Danske Spil to provide an online gaming platform for poker and casino games in Denmark. Outdoor clothing retailer Blacks Leisure said it is mulling a possible equity fundraising in the first quarter to raise between £15m and £20m depending on investor demand. It hopes to roll out new stores, having closed 87 loss-making outlets in the fourth quarter of 2009. It said trading in the ongoing stores was very healthy with like-for-like sales increasing by 12.0% in the half year ended 7 JanuaryThe US Navy has awarded defence and aerospace group Cobham a contract worth up to $11.5m for the UK group. Cobham has won the Band 5/6 TWT (Travelling-wave Tube) Replacement Module Assembly (TRMA) development contract.Stem cell therapy group ReNeuron said it is on track to start human trials of its flagship treatment ReN001 for disabled stroke patients in the first quarter of this year.EMED Mining's quest to reopen the Rio Tinto mine in Spain moved a step closer following recent court rulings deemed favourable to the company. The cases all related to objections by previous stakeholders in the mine.FTSE 100 - RisersLand Securities Group (LAND) 683.00p +2.86%TUI Travel (TT.) 271.00p +2.69%British Land Co (BLND) 473.40p +2.60%BG Group (BG.) 1,223.00p +2.43%Marks & Spencer Group (MKS) 375.00p +2.35%Cairn Energy (CNE) 370.30p +2.32%Kingfisher (KGF) 230.80p +2.30%BP (BP.) 635.50p +2.22%SEGRO (SGRO) 350.70p +1.95%Morrison (Wm) Supermarkets (MRW) 290.20p +1.90%FTSE 100 - FallersEurasian Natural Resources (ENRC) 1,010.00p -2.32%Standard Chartered (STAN) 1,590.00p -2.09%Legal & General Group (LGEN) 82.55p -2.08%SABMiller (SAB) 1,801.00p -2.01%Prudential (PRU) 626.50p -1.88%Man Group (EMG) 314.00p -1.81%Vedanta Resources (VED) 2,834.00p -1.80%Anglo American (AAL) 2,845.00p -1.79%Xstrata (XTA) 1,224.50p -1.76%Fresnillo (FRES) 852.00p -1.62%FTSE 250 - RisersRenishaw (RSW) 602.00p +5.61%St James's Place (STJ) 270.00p +5.47%Electra Private Equity (ELTA) 1,280.00p +5.09%Interserve (IRV) 229.90p +5.07%Lamprell (LAM) 211.00p +4.87%BlueBay Asset Management (BBAY) 347.40p +4.48%Halfords Group (HFD) 436.00p +4.31%Dechra Pharmaceuticals (DPH) 493.00p +4.23%Telecity Group (TCY) 424.00p +3.95%Domino Printing (DNO) 353.60p +3.66%FTSE 250 - FallersImagination Technologies (IMG) 262.80p -5.81%Weir Group (WEIR) 798.00p -4.09%Carphone Warehouse Group (CPW) 192.20p -2.88%Close Brothers Group (CBG) 712.00p -2.40%Unite Group (UTG) 289.10p -2.36%Barratt Developments (BDEV) 138.70p -2.26%Charter International (CHTR) 770.00p -2.10%SIG (SHI) 122.80p -1.92%DS Smith (SMDS) 125.70p -1.80%Investec (INVP) 454.80p -1.69%
More News
23 Nov 2021 16:02

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 Nov 2021 12:20

TRADING UPDATES: Symphony Environmental's India foray; Panthera drills

TRADING UPDATES: Symphony Environmental's India foray; Panthera drills

Read more
26 Oct 2021 19:06

TRADING UPDATES: Yellow Cake fundraises; Mercia Asset invests

TRADING UPDATES: Yellow Cake fundraises; Mercia Asset invests

Read more
26 Oct 2021 14:02

ReNeuron enters cancer therapy collaboration with UCL

(Sharecast News) - Cell-based therapeutic specialist ReNeuron has entered a collaboration agreement with University College London (UCL), it announced on Tuesday, to conduct research into the generation of immune cells from induced pluripotent stem cells (iPSCs), for anti-cancer cell therapies.

Read more
21 Oct 2021 16:40

Director dealings: Reneuron Group non-executive makes share purchase

(Sharecast News) - Reneuron Group revealed on Thursday that non-executive director Barbara Staehelin had acquired 43,000 ordinary shares in the AIM-listed cell-based therapeutics developer.

Read more
21 Oct 2021 14:07

DIRECTOR DEALINGS: Inspiration Healthcare exec sells 135,000 shares

DIRECTOR DEALINGS: Inspiration Healthcare exec sells 135,000 shares

Read more
18 Oct 2021 15:12

TRADING UPDATES: Mind Gym revenue recovers; Dispersion buys Accru

TRADING UPDATES: Mind Gym revenue recovers; Dispersion buys Accru

Read more
18 Oct 2021 09:14

ReNeuron treats first Oxford patient as part of expanded study

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group said on Monday that the first UK subject had been treated at the Oxford Eye Hospital as part of its phase 2a clinical evaluations for the treatment of retinitis pigmentosa (RP) - an inherited, degenerative eye disease.

Read more
11 Oct 2021 11:51

ReNeuron upbeat on positive data from Spain collaboration

(Sharecast News) - Exosome therapeutics developer ReNeuron announced positive data on Monday that it said provided "clear preclinical proof-of-concept" that its novel exosome drug delivery technology could effectively deliver therapeutic proteins to the specific region of the brain affected by several neurological diseases.

Read more
11 Oct 2021 11:05

IN BRIEF: ReNeuron gets positive results from exosome drug data

IN BRIEF: ReNeuron gets positive results from exosome drug data

Read more
11 Oct 2021 10:59

AIM WINNERS & LOSERS: Cadence rises on Amapa "landmark"; ASOS dives

AIM WINNERS & LOSERS: Cadence rises on Amapa "landmark"; ASOS dives

Read more
1 Oct 2021 11:15

TRADING UPDATES: Sensyne revenue jumps; Stranger Holdings loss narrows

TRADING UPDATES: Sensyne revenue jumps; Stranger Holdings loss narrows

Read more
1 Oct 2021 10:33

ReNeuron gets approval to restart RP clinical study

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group updated the market on its phase 2a clinical evaluations for the treatment of the inherited, degenerative eye disease retinitis pigmentosa on Friday, confirming that it had received regulatory approval to restart the study in all geographies.

Read more
9 Sep 2021 16:01

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
6 Aug 2021 10:55

ReNeuron taps Oxford Biomedica executive Catherine Isted as CFO

ReNeuron taps Oxford Biomedica executive Catherine Isted as CFO

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.